Bibliographic information

GuidelineTherapeutics and COVID-19: living guideline, 22 April 2022.
Year of Publication2022
Issuing InstitutionWorld Health Organization

Recommendation

Maintained

For patients with non-severe COVID-19 (who do not meet criteria for severe or critical infection). The WHO recommends against administering convalescent plasma for treatment of COVID-19

Recommended against

Strong

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

Therapeutics and COVID-19. Living guideline. 7 December 2021

Year2021
InstitutionWorld Health Organization
Guideline

Therapeutics and COVID-19: living guideline, 14 January 2022.

Year2022
InstitutionWorld Health Organization
Guideline

Therapeutics and COVID-19: living guideline, 3 March 2022.

Year2022
InstitutionWorld Health Organization
Guideline

Therapeutics and COVID-19: living guideline, 14 July 2022.

Year2022
InstitutionWHO
Guideline

Therapeutics and COVID-19: living guideline, 16 September 2022.

Year2022
InstitutionWorld Health Organization
Guideline

Therapeutics and COVID-19: living guideline, 13 January 2023.

Year2023
InstitutionWorld Health Organization
Guideline

Therapeutics and COVID-19: living guideline, 10 November 2023.

Year2023
InstitutionWorld Health Organization
Guideline

Therapeutics and COVID-19: living guideline, August 2025

Year2025
InstitutionWorld Health Organization